One of the most common consequences of holding in urine is the increased risk of urinary tract infections. When urine stays in the bladder too long, it can become a breeding ground for bacteria. These ...

Bladder cancer is a common cancer and one of the most costly to treat, yet there has been little change in the standard of care in 40 years. This panel will focus on the unmet needs in bladder cancer ...

For 25 hours and five minutes, Senator Cory Booker captured the nation’s attention by breaking the record for the longest speech in U.S. Senate history. During that time, he did not leave the Senate ...

Bottom Line: Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had ...

Patients with advanced bladder cancer have significantly less risk of the disease progressing or returning when treated with an immunotherapy drug called durvalumab, research has shown. Jörg ...

NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...

The pediatric patient described has a presumed diagnosis of secondary diurnal (daytime) enuresis, assuming that she is not bedwetting, and previously had achieved complete bladder control day and ...

TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, consistent release of chemotherapy proved far more effective than traditional ...